STOCK TITAN

Ultralife Corp - ULBI STOCK NEWS

Welcome to our dedicated news page for Ultralife (Ticker: ULBI), a resource for investors and traders seeking the latest updates and insights on Ultralife.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ultralife's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ultralife's position in the market.

Rhea-AI Summary
Ultralife (NASDAQ: ULBI) reported strong first-quarter results with sales of $41.9 million, a 31.4% increase year-over-year. Gross profit was $11.5 million, operating income reached $4.1 million, and GAAP EPS stood at $0.18. Adjusted EBITDA saw a significant gain to $5.2 million. The company emphasized gross margin improvement and growth in government/defense and medical markets. Revenue increase was driven by battery & Energy Products and Communications Systems sales growth. Ultralife remains optimistic about sustaining profitable growth, generating cash flow, and investing in new products and acquisitions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.68%
Tags
-
Rhea-AI Summary
Ultralife (NASDAQ: ULBI) will announce its first quarter results for the period ending March 31, 2024, on April 25, 2024. The company's Management will conduct an investor conference call and webcast at 8:30 AM ET on the same day. Participants are required to pre-register for the call to ensure a smooth connection.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
conferences earnings
-
Rhea-AI Summary
Ultralife Corporation (ULBI) reported strong operating results for Q4 and FY 2023, with sales reaching $44.5 million in Q4, a 23.4% YoY increase, and $158.6 million for the fiscal year, a 20.3% YoY increase. Adjusted EBITDA doubled in Q4, reaching $4.8 million, and increased to $15.7 million for the year. The company saw a significant expansion in gross margin to 24.7% for the year, resulting in adjusted EPS of $0.52. Ultralife aims to reduce debt, invest in new products, and sustain profitable growth in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.48%
Tags
Rhea-AI Summary
Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ended December 31, 2023 before the market opens on Thursday, February 15, 2024. Ultralife’s Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on February 15, 2024. Participants dialing in by phone are required to pre-register using the provided link to ensure a fast and reliable connection to the investor conference call. A live webcast of the conference call will be available to investors on the Company’s website, with a replay available shortly after the call at the same location.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.8%
Tags
conferences earnings
-
Rhea-AI Summary
Ultralife Corporation reports Q3 2023 results with sales of $39.5 million, a 18.8% YoY increase. Operating income of $2.1 million, compared to a loss of $0.6 million in Q3 2022. Adjusted EPS of $0.10, compared to a loss of $0.03 in Q3 2022. Adjusted EBITDA of $3.5 million, a 177.3% YoY increase. Backlog of $101.1 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.57%
Tags
-
Rhea-AI Summary
Ultralife Corporation to report Q3 results on October 26, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.76%
Tags
conferences earnings
Rhea-AI Summary
Ultralife Corporation (NASDAQ: ULBI) reported operating results for Q2 2023. Sales increased by 32.9% YoY to $42.7 million. Operating income was $3.7 million compared to $0.8 million in Q2 2022. Adjusted EPS was $0.29 compared to $0.03 in the previous year. Backlog increased to $110.9 million, the highest level in the company's history.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
52.54%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.58%
Tags
conferences earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.46%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.73%
Tags
conferences earnings
Ultralife Corp

Nasdaq:ULBI

ULBI Rankings

ULBI Stock Data

147.40M
10.07M
4.19%
68.59%
0.64%
Primary Battery Manufacturing
Manufacturing
Link
US
Newark

About ULBI

ultralife corporation began as a battery company and now offers products and services ranging from portable and standby power solutions to communications and electronics systems. the battery and energy products group offers a complete range of rechargeable and non-rechargeable batteries, chargers, and accessories to commercial, medical and military customers. whilst ultralife's communication systems group offers a complete set of power and amplification products that compliment many of the commercial and military portable radio and communications sets. ultralife's family of brands includes: ultralife batteries, able, mcdowell research, amti and accutronics ltd with operations in north america, europe and asia. ultralife was incorporated in 1990 and became a public company in 1992, shares trade on the nasdaq under the symbol ulbi. stay in the loop with the latest news from ultralife battery & energy or ultralife communications systems with our new linkedin showcase pages. we will be usi